Home  /  Insights  /  Regenerative science & regulation
Insights

Questions to ask any regenerative medicine clinic

Every one of these is answerable. Difficulty answering is itself information.

All insights

About the product

  • What exactly is the product, and what tissue is it derived from?
  • Who processes it, and is that establishment FDA-registered?
  • Is it regulated under Section 361 or Section 351?
  • Is it FDA-approved for the use you are proposing?
  • Is the proposed use homologous?

The expected answers for a Section 361 birth tissue product: registered not approved, Section 361, homologous use only.

About the evidence

  • What published research supports this use of this product?
  • Were those studies randomised and controlled?
  • What did studies finding no benefit report?
  • Is any registry or study enrolment being offered, and am I paying for the treatment?

About your case

  • What is my diagnosis, and what established it?
  • What conservative options remain untried?
  • What happens if I do nothing?
  • Who performs the procedure and what are their credentials?
  • What are the risks?

About cost

  • What is the total cost in writing, including follow-up?
  • Is financing offered, by whom, and on what terms?
  • What is the refund and cancellation policy?
  • What happens if there is no improvement?

Take the written information away and read it somewhere other than the clinic. Nothing legitimate requires a same-day decision.

This article covers general science and published research. Whether any approach is appropriate for you is a clinical question, answered by a licensed provider through a good-faith exam.

Talk with a provider

Educational content. This page provides general information in line with the disclosures below; it is not medical advice or a claim of results. Eligibility for any service is determined by a licensed provider through a good-faith exam.